Back
DoorDash Vs. Novo Nordisk AS Industry Stock Comparison
Buy
71
DASH
DoorDash
Last Price:
$187.69
Seasonality Move:
-6.82%
Sell
12
NVO
Novo Nordisk AS
Last Price:
$74.77
Seasonality Move:
2.91%
Sell
12
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $78.11. The Score for NVO is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
DASH Stock Price Chart
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $78.11Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
DASH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.82 | Sell |
Relative Strength Index (14 RSI): | 42.93 | Sell |
Chaikin Money Flow: | 5277016 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (187.6 - 205.02) | Sell |
Bollinger Bands (100): | (160.87 - 191.55) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 36.06 | Sell |
Chaikin Money Flow: | -163431 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.55 - 89.19) | Sell |
Bollinger Bands (100): | (84.18 - 110.22) | Sell |
DASH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 190.33 | Sell |
20-day SMA: | 197.05 | Sell |
50-day SMA: | 185.58 | Sell |
200-day SMA: | 148.18 | Buy |
8-day EMA: | 188.56 | Sell |
20-day EMA: | 192.25 | Sell |
50-day EMA: | 187 | Sell |
200-day EMA: | 156.83 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 87.62 | Sell |
20-day SMA: | 85.58 | Sell |
50-day SMA: | 85.11 | Sell |
200-day SMA: | 115.49 | Sell |
8-day EMA: | 85.96 | Sell |
20-day EMA: | 86.16 | Sell |
50-day EMA: | 88.76 | Sell |
200-day EMA: | 105.13 | Sell |
DoorDash Earnings Growth & DASH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.42 per share, an increase next quarter of $0.13 per share, an increase this year of $1.43 per share, and an increase next year of $1.51 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.11 per share, an increase this year of $0.93 per share, and an increase next year of $0.70 per share.
DoorDash Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |